Researcher.Life Logo

Therapeutic Advances in Infectious Disease : Impact Factor & More

eISSN: 2049-937XpISSN: 2049-9361
JournalOpen Access

Key Metrics

CiteScore
1.5
SJR
Q4Infectious Diseases
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Infectious Disease

Therapeutic Advances in Infectious Disease Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 1500
Publication Time9
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Infectious Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Infectious Disease

Knowledge, attitudes and practices on antimicrobial resistance among healthcare workers in sub-Saharan Africa: a systematic review and meta-analysis
  • 6 May 2026
  • Therapeutic Advances in Infectious Disease
Clinical impact of microbial cell-free DNA next-generation sequencing for invasive mold infection—a single-center retrospective observational study
  • 3 Apr 2026
  • Therapeutic Advances in Infectious Disease
A new multiplex molecular assay based on padlock probes and rolling circle amplification for MDR-TB detection in clinical specimens: a prospective diagnostic accuracy study.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
Enterovirus D68 and mycobacterial coinfection: case report.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
The interplay between chronic kidney disease and urinary tract infections: a comprehensive review on the pathophysiological insights, interconnected burdens, and prevention strategies.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
Assessing pneumonia severity using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: a cross-sectional comparison with CURB-65 score.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
Knowledge, attitudes and practices on antimicrobial resistance among healthcare workers in sub-Saharan Africa: a systematic review and meta-analysis
  • 6 May 2026
  • Therapeutic Advances in Infectious Disease
Clinical impact of microbial cell-free DNA next-generation sequencing for invasive mold infection—a single-center retrospective observational study
  • 3 Apr 2026
  • Therapeutic Advances in Infectious Disease
A new multiplex molecular assay based on padlock probes and rolling circle amplification for MDR-TB detection in clinical specimens: a prospective diagnostic accuracy study.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
Enterovirus D68 and mycobacterial coinfection: case report.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
The interplay between chronic kidney disease and urinary tract infections: a comprehensive review on the pathophysiological insights, interconnected burdens, and prevention strategies.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease
Assessing pneumonia severity using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: a cross-sectional comparison with CURB-65 score.
  • 1 Apr 2026
  • Therapeutic advances in infectious disease

FAQs on Therapeutic Advances in Infectious Disease